| Dr Stacey C Muhammad, MD | |
|
501 W Medical Center Blvd, Webster, TX 77598-4219 | |
| (281) 332-7505 | |
| (281) 332-7616 |
| Full Name | Dr Stacey C Muhammad |
|---|---|
| Gender | Female |
| Speciality | Hospice/palliative Care |
| Experience | 25 Years |
| Location | 501 W Medical Center Blvd, Webster, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366439853 | NPI | - | NPPES |
| 157538302 | Medicaid | TX |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
Blocking a factor that can activate the human immune response against intestinal bacteria or certain foods could prevent the development of celiac disease in those most at risk, researchers report in the journal Nature.
In a speech at the World Food Prize conference on Thursday, former U.N. Secretary-General Kofi Annan discussed several topics related to food security and said that discrimination against women is limiting agricultural development in Africa, the Des Moines Register reports.
The Physicians Committee for Responsible Medicine has called for the Food and Drug Administration (FDA) to push for cheese manufacturers to place breast cancer warning labels on their products.
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
› Verified 5 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
Blocking a factor that can activate the human immune response against intestinal bacteria or certain foods could prevent the development of celiac disease in those most at risk, researchers report in the journal Nature.
In a speech at the World Food Prize conference on Thursday, former U.N. Secretary-General Kofi Annan discussed several topics related to food security and said that discrimination against women is limiting agricultural development in Africa, the Des Moines Register reports.
The Physicians Committee for Responsible Medicine has called for the Food and Drug Administration (FDA) to push for cheese manufacturers to place breast cancer warning labels on their products.
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
› Verified 5 days ago
| Entity Name | Memorial Hermann Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Blocking a factor that can activate the human immune response against intestinal bacteria or certain foods could prevent the development of celiac disease in those most at risk, researchers report in the journal Nature.
In a speech at the World Food Prize conference on Thursday, former U.N. Secretary-General Kofi Annan discussed several topics related to food security and said that discrimination against women is limiting agricultural development in Africa, the Des Moines Register reports.
The Physicians Committee for Responsible Medicine has called for the Food and Drug Administration (FDA) to push for cheese manufacturers to place breast cancer warning labels on their products.
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stacey C Muhammad, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Dr Stacey C Muhammad, MD 501 W Medical Center Blvd, Webster, TX 77598-4219 Ph: (281) 332-7505 |
News Archive
Blocking a factor that can activate the human immune response against intestinal bacteria or certain foods could prevent the development of celiac disease in those most at risk, researchers report in the journal Nature.
In a speech at the World Food Prize conference on Thursday, former U.N. Secretary-General Kofi Annan discussed several topics related to food security and said that discrimination against women is limiting agricultural development in Africa, the Des Moines Register reports.
The Physicians Committee for Responsible Medicine has called for the Food and Drug Administration (FDA) to push for cheese manufacturers to place breast cancer warning labels on their products.
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
› Verified 5 days ago
Dr. Atul Matta, M.B.B.S Internal Medicine Medicare: Medicare Enrolled Practice Location: 200 Blossom St, Webster, TX 77598 Phone: 832-632-6500 | |
Niraj Choudhary, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 E Medical Center Blvd, Suite A, Webster, TX 77598 Phone: 832-932-5669 Fax: 832-932-5249 | |
Maha Khalifa Al-lahiq, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 N Kobayashi, Suite A, Webster, TX 77598 Phone: 281-724-1860 Fax: 281-724-1861 | |
Dr. Alfred Salim Maksoud, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Orchard St, Suite 200, Webster, TX 77598 Phone: 281-557-8555 | |
Dr. Snehalkumar Arjunbhai Patel, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Blossom St, Suite C, Webster, TX 77598 Phone: 832-376-8500 Fax: 832-376-8505 | |
Souad Enakuaa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 N Kobayashi Ste 312, Webster, TX 77598 Phone: 281-724-8333 Fax: 281-336-1680 | |
Vikas Jogi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 N Kobayashi Ste 308, Webster, TX 77598 Phone: 281-724-8336 Fax: 281-336-1619 |